Aprobación de fda de stock itci
12/19/2018 · Intra-Cellular Therapies Inc (NASDAQ:ITCI) was in 16 hedge funds' portfolios at the end of the third quarter of 2018. ITCI investors should pay attention to a decrease in enthusiasm from smart money lately. There were 18 hedge funds in our database with ITCI holdings at the end of the previous quarter. Un tratamiento experimental para el cáncer de páncreas puede o no tener la aprobación de la FDA para tratar otra enfermedad o afección. pancreaticcancer.org The su perior mesenteric artery is located near the pancreas and supplies blood to the small intestines, colon, and part o f the p an creas. ITCI - Intra-Cellular Therapies Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.